Encoded Therapeutics
Translating Next-Generation Science into Transformative Gene Therapies
South San Francisco, United States · Founded 2014 · $239.0M raised
- Headquarters
- South San Francisco, California
- Employees
- 51–200
- Founded
- 2014
- Business Model
- B2B
- Website
- encoded.com
- Total Funding
- $239.0M
- Last Round
- $135.0M Series DJul 2020
- Rounds
- 3
About
Encoded Therapeutics is a clinical-stage biotech company developing precision genetic medicines for severe pediatric central nervous system disorders, with a lead program targeting SCN1A+ Dravet syndrome. The company's novel targeting and regulation platform enables cell-type-specific gene expression, overcoming limitations of first-generation gene therapies. In January 2026, ETX101 received FDA Breakthrough Therapy Designation for the treatment of Dravet syndrome.
Summary
Encoded Therapeutics is a Biotech company based in South San Francisco, United States, founded in 2014. It has raised $239.0M in total across 3 rounds, most recently a $135.0M Series D round in Jul 2020. Investors include ARCH Venture Partners, Venrock and GV.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2020
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
ARCH Venture Partners
3 rounds
Venrock
2 rounds
GV
1 round
Matrix Capital Management
2 rounds
Illumina Ventures
2 rounds
RTW Investments
2 rounds
Boxer Capital
2 rounds
Menlo Ventures
2 rounds
Nolan Capital
1 round
HBM Genomics
1 round
Meritech Capital Partners
1 round
Farallon Capital
1 round
.png)
SoftBank
1 round
Altitude Life Science Ventures
1 round
Alexandria Venture Investments
1 round
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Clinical-stage biotechnology company developing T-cell engager therapeutics for autoimmune and in...